Asymchem Laboratories Tianjin
Asymchem Laboratories (Tianjin) Co Ltd is a Chinese contract development and manufacturing organization (CDMO) providing chemical synthesis and biopharmaceutical manufacturing services globally. The company offers active pharmaceutical ingredient (API) development, clinical trial supply, commercial drug synthesis, and bioprocess engineering. Principal revenues derive from fee-for-service chemical development contracts, process optimization fees, and commercial drug substance supply to global biopharmaceutical firms. Core end markets encompass multinational pharmaceutical corporations, biotechnology startups, and clinical research institutes across North America, Europe, and Asia-Pacific. Asymchem Laboratories holds a market-leading position in global pharmaceutical contract synthesis and continuous flow manufacturing technology. The company is headquartered in Tianjin, China, and its shares trade on the Shenzhen Stock Exchange and Stock Exchange of Hong Kong.
2 of the funds FundTelligence covers report a position in Asymchem Laboratories Tianjin.
- Legal name
- Asymchem Laboratories Tianjin Co Ltd
- Sector
- Health Care
- Country
- China
- Funds holding it
- 2
Funds holding Asymchem Laboratories Tianjin
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.07 % (full portfolio disclosed, September 2026)
- Handelsbanken Global Index Criteria — Handelsbanken · 0.03 % (full portfolio disclosed, September 2026)